UPDATE: uniQure On AMT-060 Says, 'Second-dose Cohort Demonstrates Dose Response Up to One Year, with 84% Reduction in Spontaneous Bleeds and All Patients Free of Prophylactic FIX Replacement Therapy'
Paul Quintaro